|
biofilm |
18 |
|
microbiology |
12 |
|
biofilms |
11 |
|
caries |
10 |
|
antimicrobial agents/inhibitors |
9 |
|
enterococcus faecalis |
9 |
|
fungi |
8 |
|
immunology |
8 |
|
infection |
8 |
|
bacteria |
7 |
|
biofilms - drug effects |
7 |
|
candida |
7 |
|
candida albicans |
7 |
|
dentistry |
7 |
|
inflammatory mediators |
7 |
|
medical sciences |
7 |
|
anti-bacterial agents - pharmacology |
6 |
|
antifungal agents - pharmacology |
6 |
|
antimicrobial |
6 |
|
antimicrobial effect |
6 |
|
behavioral science |
6 |
|
candida glabrata |
6 |
|
cross-professional |
6 |
|
drugs, chinese herbal - chemistry - pharmacology |
6 |
|
drugs, chinese herbal - pharmacology |
6 |
|
fructus mume |
6 |
|
health services research and learning |
6 |
|
host-microbial interactions |
6 |
|
innate immune response |
6 |
|
lipoteichoic acid |
6 |
|
molecular biology |
6 |
|
orthodontic |
6 |
|
orthodontic brackets - microbiology |
6 |
|
periodontics |
6 |
|
plant extracts - analysis - pharmacology |
6 |
|
root canal infection |
6 |
|
saliva |
6 |
|
signaling pathways |
6 |
|
anti-infective agents, local - administration and dosage - pharmacology |
5 |
|
bisphosphonate-related osteonecrosis of the jaws |
5 |
|
candida - growth & development - metabolism |
5 |
|
candida biofilms |
5 |
|
cell adhesion |
5 |
|
children |
5 |
|
chinese medicine |
5 |
|
chlorhexidine - administration and dosage - analogs and derivatives - pharmacology |
5 |
|
cytokine |
5 |
|
dietary sucrose - metabolism |
5 |
|
diffusion |
5 |
|
drug resistance, fungal |
5 |
|
galactose - metabolism |
5 |
|
gene expression |
5 |
|
glucose - metabolism |
5 |
|
hatr-ftir |
5 |
|
immune response |
5 |
|
microscopy, confocal |
5 |
|
mouthwashes - administration and dosage - pharmacology |
5 |
|
oral biofilm |
5 |
|
orthodontics |
5 |
|
ovariectomy |
5 |
|
periodontal disease |
5 |
|
periodontal organisms |
5 |
|
periodontitis |
5 |
|
plant extracts - pharmacology |
5 |
|
poly(methyl methacrylate) |
5 |
|
porphyromonas gingivalis - drug effects |
5 |
|
proteins |
5 |
|
proteome |
5 |
|
proteomics |
5 |
|
prunus |
5 |
|
rat |
5 |
|
s. mutans and saliva |
5 |
|
spectroscopy, fourier transform infrared |
5 |
|
sucrose - metabolism |
5 |
|
sugars |
5 |
|
zoledronic acid |
5 |
|
2-d dige |
4 |
|
2-de |
4 |
|
actinomyces - drug effects |
4 |
|
alkaline phosphatase activity |
4 |
|
amino acid sequence |
4 |
|
animal |
4 |
|
anti-oxidant activity |
4 |
|
antifungal |
4 |
|
antifungal susceptibility |
4 |
|
antimicrobials |
4 |
|
antioxidants - physiology |
4 |
|
architecture |
4 |
|
bacteria - drug effects |
4 |
|
biofilms - drug effects - growth & development |
4 |
|
biofilms - drug effects - growth and development |
4 |
|
biofilms - growth & development |
4 |
|
biomarker |
4 |
|
biomass |
4 |
|
bone calcium deposition |
4 |
|
candida albicans - genetics - pathogenicity - ultrastructure |
4 |
|
candida albicans - growth & development |
4 |
|
candida glabrata - drug effects - genetics - metabolism - physiology |
4 |
|
candida glabrata - growth & development |
4 |
|
cariology |
4 |
|
cariostatic agents - pharmacology |
4 |
|
chemicals and cas registry numbers |
4 |
|
chlorhexidine |
4 |
|
colony count, microbial |
4 |
|
dental caries - microbiology - pathology - prevention and control |
4 |
|
dentin |
4 |
|
dentin - drug effects - microbiology - pathology - ultrastructure |
4 |
|
drug resistance, fungal - genetics |
4 |
|
drug resistance, multiple, bacterial |
4 |
|
electrophoresis, gel, two-dimensional |
4 |
|
enterococcus facaelis |
4 |
|
fluoride |
4 |
|
fungi - drug effects - physiology |
4 |
|
gene expression profiling |
4 |
|
growth kinetics |
4 |
|
inflammation |
4 |
|
mapk signaling pathways |
4 |
|
microbial viability |
4 |
|
microbiology and nucleic acids |
4 |
|
microscopy, electron, scanning |
4 |
|
nanotechnology |
4 |
|
oral biofilms |
4 |
|
osteoblasts |
4 |
|
osteoclasts |
4 |
|
periapical periodontitis |
4 |
|
persistent apical periodontitis |
4 |
|
polymerase chain reaction |
4 |
|
polystyrenes |
4 |
|
proteomics - methods |
4 |
|
quaternary ammonium compounds - pharmacology |
4 |
|
receptor activator of nuclear factor-kappa b ligand |
4 |
|
resistance |
4 |
|
scutellaria baicalensis |
4 |
|
software |
4 |
|
stress response |
4 |
|
stress, physiological |
4 |
|
therapeutics |
4 |
|
viability |
4 |
|
acrylic resins |
3 |
|
acrylics |
3 |
|
adherence and colonization |
3 |
|
antifungal drug |
3 |
|
antifungal resistance |
3 |
|
antifungals |
3 |
|
bacteria - growth & development |
3 |
|
biofilms - growth and development |
3 |
|
bloodstream isolates |
3 |
|
c. albicans biofilm |
3 |
|
c. albicans biofilms |
3 |
|
candida - drug effects |
3 |
|
candida - drug effects - growth & development |
3 |
|
candida - growth & development - physiology |
3 |
|
candida albicans - chemistry - drug effects |
3 |
|
candida albicans - drug effects - growth & development - ultrastructure |
3 |
|
candida dubliniensis |
3 |
|
candida krusei |
3 |
|
candida tropicalis |
3 |
|
cell culture |
3 |
|
clinical isolates |
3 |
|
cost |
3 |
|
crevicular fluid |
3 |
|
cytokines |
3 |
|
dental materials |
3 |
|
denture |
3 |
|
denture acrylic |
3 |
|
denture bases - microbiology |
3 |
|
denture cleaning methods |
3 |
|
dose-response relationship, drug |
3 |
|
drug combinations |
3 |
|
drug evaluation, preclinical - methods |
3 |
|
drug synergism |
3 |
|
equipment contamination |
3 |
|
fibroblasts |
3 |
|
gingivitis |
3 |
|
human gingival fibroblasts |
3 |
|
humans |
3 |
|
indoles - pharmacology |
3 |
|
infection and periodontal disease |
3 |
|
issatchenkia orientalis |
3 |
|
lipid a heterogeneity |
3 |
|
lipopolysaccharide |
3 |
|
low-cost powered toothbrush |
3 |
|
lysozyme |
3 |
|
metergoline |
3 |
|
microbial sensitivity tests |
3 |
|
microbial sensitivity tests - methods |
3 |
|
microbiology and periodontal disease |
3 |
|
microbiology and plaque |
3 |
|
mmps |
3 |
|
muramidase - pharmacology |
3 |
|
oral biology |
3 |
|
organosilicon compounds - pharmacology |
3 |
|
p. gingivalis lps |
3 |
|
phospholipase |
3 |
|
photodynamic therapy |
3 |
|
photosensitiser |
3 |
|
photosensitizing agents - pharmacology |
3 |
|
phthalocyanine |
3 |
|
plasma protein binding |
3 |
|
porphyromonas gingivalis |
3 |
|
prostheses |
3 |
|
rotating disc |
3 |
|
species index: candida |
3 |
|
synergism |
3 |
|
virulence attributes |
3 |
|
virulence factors |
3 |
|
adhesion |
2 |
|
antifungal agents - metabolism - pharmacology |
2 |
|
apoptosis |
2 |
|
bacterial |
2 |
|
biocides |
2 |
|
biomarker discovery |
2 |
|
black fungus |
2 |
|
candida albicans - drug effects - genetics - growth & development |
2 |
|
candida albicans - drug effects - genetics - growth and development |
2 |
|
candida albicans - drug effects - physiology |
2 |
|
candida albicans - growth and development - ultrastructure |
2 |
|
culture media |
2 |
|
dental caries - microbiology |
2 |
|
dental plaque - microbiology |
2 |
|
disinfectants - pharmacology |
2 |
|
elderly |
2 |
|
escherichia coli |
2 |
|
fungal proteins - genetics - metabolism |
2 |
|
gene expression regulation, fungal |
2 |
|
gene expression regulation, fungal - drug effects |
2 |
|
hemin |
2 |
|
hyphae - genetics |
2 |
|
hyphae - genetics - growth & development |
2 |
|
hyphal mutants |
2 |
|
inflammatory mediators and periodontal disease |
2 |
|
inflammatory response |
2 |
|
low abundant protein |
2 |
|
mass spectrometry |
2 |
|
mesoporous silica nanoparticles |
2 |
|
monocytes |
2 |
|
mutation |
2 |
|
nano-chlorhexidine |
2 |
|
non-albicans candida |
2 |
|
oral cavity |
2 |
|
oral health |
2 |
|
pathogenicity |
2 |
|
periodontal disease and periodontal organisms |
2 |
|
periodontal diseases |
2 |
|
periodontal diseases - microbiology |
2 |
|
periodontium-gingiva |
2 |
|
persister |
2 |
|
plankton - drug effects - growth & development |
2 |
|
polymethyl methacrylate - chemistry |
2 |
|
sample prefractionation |
2 |
|
surface properties |
2 |
|
two-dimensional gel electrophoresis |
2 |
|
virulence |
2 |
|
xtt |
2 |
|
yeasts |
2 |
|
biofilms. |
1 |
|
candida albicans. |
1 |
|
denaturing gradient gel electrophoresis |
1 |
|
dental restorative materials |
1 |
|
microbial diversity |
1 |
|
molecular biology. |
1 |
